Thr-Leu pairs polar threonine with hydrophobic leucine to model early-stage folding behaviors. The dipeptide enables detailed examination of hydrogen bonding and amphipathic tendencies. Researchers explore its solution dynamics and enzymatic recognition patterns. Applications include structural modeling, motif analysis, and peptide-synthesis refinement.
CAT No: R2664
CAS No:50299-12-2
Synonyms/Alias:H-Thr-Leu-OH;Thr-Leu;50299-12-2;L-threonyl-L-leucine;threonylleucine;CHEBI:74860;(2S)-2-[[(2S,3R)-2-amino-3-hydroxybutanoyl]amino]-4-methylpentanoic acid;(S)-2-((2S,3R)-2-Amino-3-hydroxybutanamido)-4-methylpentanoic acid;Threoninylleucine;Threonyl-leucine;TL dipeptide;T-L Dipeptide;Threoninyl-Leucine;H-Thr-Leu;MFCD00083825;L-Thr-L-Leu;L-Threoninyl-L-Leucine;Threonine Leucine dipeptide;Threonine-Leucine dipeptide;CHEMBL1221899;SCHEMBL14842720;BQBCIBCLXBKYHW-CSMHCCOUSA-N;AS-82914;FT108186;CS-0453119;G77914;Q27144970;(2S)-2-[(2S,3R)-2-AMINO-3-HYDROXYBUTANAMIDO]-4-METHYLPENTANOIC ACID;
4. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review
5. Emu oil in combination with other active ingredients for treating skin imperfections
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.